Highlights and Quick Summary
- Capex to Sales for the quarter ending June 30, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Capex to Sales decreased by NaN%
- Annual Capex to Sales for 2021 was 0.02 (a Infinity% increase from previous year)
- Annual Capex to Sales for 2021 was 0.0 (a -100.0% decrease from previous year)
- Annual Capex to Sales for 2020 was 0.02 (a Infinity% increase from previous year)
- Twelve month Capex to Sales ending June 30, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
- Twelve month trailing Capex to Sales decreased by NaN% year-over-year
Trailing Capex to Sales for the last four month:
| 30 Jun '22 | 31 Mar '22 | 31 Dec '21 | 30 Sep '21 |
|---|---|---|---|
| 0.0 | 0.0 | 0.0 | 0.0 |
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capex to Sales of Biofrontera AG Sponsored ADR
Most recent Capex to Salesof BFAGY including historical data for past 10 years.Interactive Chart of Capex to Sales of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Capex to Sales for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | 0.0 | 0.0 | – |
| 2021 | 0.0 | 0.0 | 0.04 | 0.0 | 0.02 |
| 2020 | 0.0 | 0.0 | 0.05 | 0.0 | 0.02 |
| 2019 | – | 0.0 | 0.0 | 0.0 | 0.06 |
| 2018 | – | – | – | 0.07 | 0.02 |
| 2017 | – | – | 0.11 | 0.03 | 0.03 |
| 2016 | 0.14 | – | – | – | 0.07 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic